IMVT
Immunovant, Inc. · Healthcare
Chief Medical Officer Michael Geffner sold $96K of Immunovant, Inc.
Sold$95,939
$27.76Price
3,456Shares
−2%Stake
What IMVT did after the filing
- The stock from Fri, Jul 26 close, $29.10
- +8.0%
- S&P 500, same days
- +0.4%
Measured over 30 trading days, to the Sep 9 close.
Traded Wed, Jul 24. Filed Fri, Jul 26, 12:19 PM ET, during the session. Returns use the Jul 26 close and the Sep 9 close. Not investment advice.